In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from animal testing toward new approaches. One year later, much speculation ...
Nia Therapeutics announced that the U.S. Food and Drug Administration has granted Breakthrough Device Designation to its Smart Neurostimulation System (SNS) for the treatment of episodic memory loss ...
Advances in organ and computer models are raising the prospect that some animal experiments could be eliminated. But there ...
In 2025, the U.S. Food and Drug Administration finalized guidance on Computer Software Assurance (CSA), explicitly endorsing a risk-based framework for software used in device production and quality ...
The Trump administration is redoubling its efforts to phase out animal testing in drug development and seeking to develop new biotechnology methods instead to spur innovation in the pharmaceutical ...
A curated partner ecosystem uniting methodology, technology, and managed services to move life sciences from compliance ...
Pattern Computer(R), Inc. ("Pattern" or "the Company"), the global leader in Pattern Discovery, today announced expanded global intellectual property protection for its investigational cancer therapy ...
Renowned founder and robotics visionary joins AiM at a pivotal growth inflection point —WORCESTER, Mass., March 11, 2026 (GLOBE NEWSWIRE) -- ...
Asia's best solutions partner, will participate in NVIDIA GTC for the third consecutive year under the theme "From AI to Action: Physical AI in Motion." Together with ecosystem partners, EDOM will ...
Live Science spoke with the scientists behind an upcoming clinical trial testing an immune therapy for depression.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results